Previous 10 | Next 10 |
home / stock / bayzf / bayzf news
TherapeuticsMD’s $177 million buyout deal with EW Healthcare largely undervalues the biotech. TherapeuticsMD is close to stimulating the commercialization of Annovera which may increase its value as a standalone company in the long run. Shareholders were informed of a 50:1 ...
Dr. Reddy's Laboratories (NYSE:RDY) launched its sorafenib tablets, a generic of Bayer's (OTCPK:BAYRY) (OTCPK:BAYZF) kidney/liver/thyroid cancer drug Nexavar (sorafenib), in the U.S. following the approval by the U.S. Food and Drug Administration (FDA). Dr. Reddy's sorafenib tablet...
Illumina (NASDAQ:ILMN) said it added a companion diagnostic (CDx) indication to its CE-marked in vitro diagnostic TruSight Oncology (TSO) comprehensive (EU) test. The company said the CDx pan-cancer indication enables targeted therapy with Bayer's (OTCPK:BAYRY) (OTCPK:BAYZF) Vi...
Atara Biotherapeutics (NASDAQ:ATRA), a biotech focused on immunotherapies, continues to trade lower on Monday after announcing that German conglomerate Bayer (OTCPK:BAYRY) (OTCPK:BAYZF) decided to end a licensing deal with the company for two of its CAR T-cell therapies. In reaction, H.C...
Jiangsu Hengrui Pharma launched a new global company, Luzsana Biotechnology, devoted to making the most advanced medications available and affordable in global markets. Shanghai Belief Biomed reported that positive results from an investigator-led clinical trial of its gene therapy fo...
The following slide deck was published by Bayer Aktiengesellschaft in conjunction with this event. For further details see: Bayer Aktiengesellschaft (BAYRY) Presents At BMO Global Farm to Market Conference
Atara Biotherapeutics (NASDAQ:ATRA) on Thursday said its collaboration partner Bayer (OTCPK:BAYRY) (OTCPK:BAYZF) had decided to end the exclusive worldwide licensing agreement between the companies to develop CAR T-cell therapies. ATRA stock slides 15.4% to $4.34 in aftermarket trad...
Lannett (NYSE:LCI) signed an agreement with Areva Pharmaceuticals to be the exclusive U.S. distributor of Fludarabine Phosphate for injection, a generic version of Bayer's (OTCPK:BAYRY) (OTCPK:BAYZF) Fludara to treat chronic lymphocytic leukemia. Trevose, Pa.-based L...
The following slide deck was published by Bayer Aktiengesellschaft in conjunction with their 2022 Q1 earnings call. For further details see: Bayer Aktiengesellschaft 2022 Q1 - Results - Earnings Call Presentation
Bayer's defensive business mix, along with prodding for change from an activist investor, seemed to catalyze the stock's outperformance during Q1 2022. Mittleman Investement Management (MIM) hasn't owned a large cap pharmaceutical company since a very successful foray into Pfizer just...
News, Short Squeeze, Breakout and More Instantly...
Bayer AG Registered Shares Company Name:
BAYZF Stock Symbol:
OTCMKTS Market:
NORTHAMPTON, MA / ACCESSWIRE / August 29, 2023 / Bayer - As climate change quickens, societal expectations increase and the threat of resistance grows, new crop protection solutions are imperative. Advances in the life sciences and data-driven technologies hold the key to expanding our pipeline ...
Monsanto Must Face Georgia State Jurors in Lawsuit Over Cancer-Causing Roundup Herbicide PR Newswire 11th Circuit opinion finds chemical giant subject to state's warning label laws Nachawati Law Group trial lawyers gearing up for next Roundup cancer trial in Au...
Bayer Runs Out of Appeals at US Supreme Court as Thousands of Cancer Lawsuits Await over Roundup Herbicide PR Newswire Fears Nachawati trial lawyers gearing up for next Roundup cancer trial in August WASHINGTON , June 22, 2022 /PRNewswire/ -- Baye...